{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:56:02Z","timestamp":1793508962527,"version":"4.5.0"},"reference-count":35,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Context: Patients with congenital adrenal hyperplasia (CAH) receive glucocorticoids as replacement therapy. Glucocorticoid therapy is the most frequent cause of drug-induced osteoporosis.<\/jats:p>\n               <jats:p>Objective: The objective of the study was to evaluate bone mineral density (BMD) and bone metabolism in CAH patients.<\/jats:p>\n               <jats:p>Design: This was a cross-sectional observational study.<\/jats:p>\n               <jats:p>Setting: The study was conducted at a referral center for pediatric endocrinology.<\/jats:p>\n               <jats:p>Patients and Other Participants: Thirty young patients with the classical form of CAH (aged 16.4\u201329.7 yr) treated with glucocorticoid from diagnosis (duration of treatment 16.4\u201329.5 yr) and 138 healthy controls (aged 16.0\u201330.0 yr) were enrolled.<\/jats:p>\n               <jats:p>Main Outcome Measures: BMD was measured in the lumbar spine and whole body by dual-energy x-ray absorptiometry. Bone formation and resorption rates were estimated by serum measurements of bone-specific alkaline phosphatase and C-terminal telopeptide of type I collagen, respectively.<\/jats:p>\n               <jats:p>Results: CAH patients were shorter than controls (women \u22126.8 and men \u221213.3 cm). Therefore, several methods were used to account for the effect of this difference on bone measurements. Whole-body BMD measurements were significantly lower, compared with controls (P &amp;lt; 0.03), after controlling for height (on average \u22122.5% in females and \u22129.3% in male patients). No differences were found in lumbar spine measurements. Bone-specific alkaline phosphatase and C-terminal telopeptide of type I collagen serum concentrations were higher in CAH patients than control subjects (P &amp;lt; 0.04). BMD measurements and bone metabolism markers did not correlate with the actual glucocorticoid dose or mean dose over the previous 7 yr.<\/jats:p>\n               <jats:p>Conclusions: Young adult patients with the classical form of CAH have decreased bone density values, compared with healthy controls. This may put them at risk of developing osteoporosis early in life.<\/jats:p>","DOI":"10.1210\/jc.2005-2823","type":"journal-article","created":{"date-parts":[[2006,8,23]],"date-time":"2006-08-23T03:44:04Z","timestamp":1156304644000},"page":"4453-4458","source":"Crossref","is-referenced-by-count":66,"title":["Reduced Bone Mineral Density and Increased Bone Metabolism Rate in Young Adult Patients with 21-Hydroxylase Deficiency"],"prefix":"10.1210","volume":"91","author":[{"given":"Mariateresa","family":"Sciannamblo","sequence":"first","affiliation":[{"name":"Laboratory of Pediatric Endocrinology and Department of Pediatrics, San Raffaele Scientific Institute, Vita-Salute S. Raffaele University, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Russo","sequence":"additional","affiliation":[{"name":"Laboratory of Pediatric Endocrinology and Department of Pediatrics, San Raffaele Scientific Institute, Vita-Salute S. Raffaele University, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Cuccato","sequence":"additional","affiliation":[{"name":"Laboratory of Pediatric Endocrinology and Department of Pediatrics, San Raffaele Scientific Institute, Vita-Salute S. Raffaele University, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Chiumello","sequence":"additional","affiliation":[{"name":"Laboratory of Pediatric Endocrinology and Department of Pediatrics, San Raffaele Scientific Institute, Vita-Salute S. Raffaele University, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Mora","sequence":"additional","affiliation":[{"name":"Laboratory of Pediatric Endocrinology and Department of Pediatrics, San Raffaele Scientific Institute, Vita-Salute S. Raffaele University, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071614103762300_R1","first-page":"245","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"21","author":"White","year":"2000","journal-title":"Endocr Rev"},{"key":"2020071614103762300_R2","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1210\/jc.2002-020611","article-title":"Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology","volume":"87","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614103762300_R3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.7326\/0003-4819-136-4-200202190-00012","article-title":"NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"136","author":"Merke","year":"2002","journal-title":"Ann Intern Med"},{"key":"2020071614103762300_R4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0889-8529(02)00064-6","article-title":"Glucocorticoid-induced osteoporosis","volume":"32","author":"Saag","year":"2003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020071614103762300_R5","first-page":"317","article-title":"Advances in glucocorticoid therapy","volume":"45","author":"Boxter","year":"2000","journal-title":"Adv Intern Med"},{"key":"2020071614103762300_R6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/00002512-199812060-00005","article-title":"Pathogenesis and treatment of glucocorticoid-induced osteoporosis","volume":"12","author":"Rackoff","year":"1998","journal-title":"Drugs Aging"},{"key":"2020071614103762300_R7","first-page":"77","article-title":"Glucocorticoid-induced osteoporosis","volume":"60","author":"Compston","year":"2003","journal-title":"Horm Res"},{"key":"2020071614103762300_R8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0149-2918(04)90001-X","article-title":"Secondary osteoporosis: underlying disease and the risk of glucocorticoid-induced osteoporosis","volume":"26","author":"Boling","year":"2004","journal-title":"Clin Ther"},{"key":"2020071614103762300_R9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.7326\/0003-4819-120-3-199402010-00005","article-title":"Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease","volume":"120","author":"Zelissen","year":"1994","journal-title":"Ann Intern Med"},{"key":"2020071614103762300_R10","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1203\/00006450-199305001-00467","article-title":"Increased bone mineral density in congenital adrenal hyperplasia","volume":"33","author":"Speiser","year":"1993","journal-title":"Pediatr Res"},{"key":"2020071614103762300_R11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/meta.2001.21678","article-title":"Preliminary report: effect of adrenal androgen and estrogen on bone maturation and bone mineral density","volume":"50","author":"Arisaka","year":"2001","journal-title":"Metabolism"},{"key":"2020071614103762300_R12","first-page":"2238","article-title":"Bone mineral density and body composition in congenital adrenal hyperplasia","volume":"80","author":"Cameron","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614103762300_R13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2265.1996.8620871.x","article-title":"Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency","volume":"45","author":"Ja\u0308a\u0308skela\u0308inen","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614103762300_R14","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1210\/jcem.82.12.4320","article-title":"The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia","volume":"82","author":"Girgis","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614103762300_R15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1530\/eje.0.1430667","article-title":"Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy","volume":"143","author":"Hagenfeldt","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"2020071614103762300_R16","first-page":"164","article-title":"Height, bone mineral density and bone markers in congenital adrenal hyperplasia","volume":"54","author":"Paganini","year":"2000","journal-title":"Horm Res"},{"key":"2020071614103762300_R17","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00774-003-0434-6","article-title":"Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross sectional study of factors involved in bone mineral density","volume":"21","author":"Oliveira de Almeida Freire","year":"2003","journal-title":"J Bone Miner Metab"},{"key":"2020071614103762300_R18","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1210\/jc.2005-0745","article-title":"Long-term glucocorticoid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia","volume":"91","author":"King","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614103762300_R19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2265.1996.00851.x","article-title":"Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia","volume":"45","author":"Guo","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614103762300_R20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/8756-3282(96)00003-8","article-title":"Bone density in young patients with congenital adrenal hyperplasia","volume":"18","author":"Mora","year":"1996","journal-title":"Bone"},{"key":"2020071614103762300_R21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1542\/peds.100.4.671","article-title":"Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia","volume":"100","author":"Gussinye\u0301","year":"1997","journal-title":"Pediatrics"},{"key":"2020071614103762300_R22","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1210\/jc.2002-021074","article-title":"Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia","volume":"88","author":"Stikkelbroeck","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614103762300_R23","first-page":"133","article-title":"Normal bone mineral content in young adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"61","author":"Christiansen","year":"2004","journal-title":"Horm Res"},{"key":"2020071614103762300_R24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1259\/bjr.70.835.9245884","article-title":"Radiation dose and in vitro precision in paediatric bone mineral density measurement using dual X-ray absorptiometry","volume":"70","author":"Njeh","year":"1997","journal-title":"Br J Radiol"},{"key":"2020071614103762300_R25","first-page":"303","article-title":"Noninvasive techniques for bone mass measurement","author":"Mora","year":"2003","journal-title":"In: Glorieux FH, Pettifor JM, Ju\u0308ppner H, eds. Pediatric bone. Biology, diseases. San Diego: Academic Press;"},{"key":"2020071614103762300_R26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/ajcn\/60.6.837","article-title":"Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants","volume":"60","author":"Prentice","year":"1994","journal-title":"Am J Clin Nutr"},{"key":"2020071614103762300_R27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbmr.5650070204","article-title":"New approaches for interpreting projected bone densitometry data","volume":"7","author":"Carter","year":"1992","journal-title":"J Bone Miner Res"},{"key":"2020071614103762300_R28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bone.2005.04.028","article-title":"Dual X-ray absorptiometry (DXA) of the lumbar spine in a clinical paediatric setting: does the method of size-adjustment matter?","volume":"37","author":"Fewtrell","year":"2005","journal-title":"Bone"},{"key":"2020071614103762300_R29","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1210\/jcem-73-6-1332","article-title":"Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls","volume":"73","author":"Katzman","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614103762300_R30","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1172\/JCI117925","article-title":"Vertebral size in elderly women with osteoporosis. Mechanical implications and relationship to fractures","volume":"95","author":"Gilsanz","year":"1995","journal-title":"J Clin Invest"},{"key":"2020071614103762300_R31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s001980050251","article-title":"Bone mineral density in patients with treated Addison\u2019s disease","volume":"10","author":"Braatvedt","year":"1999","journal-title":"Osteoporos Int"},{"key":"2020071614103762300_R32","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1365-2265.2003.01761.x","article-title":"Long-term follow-up of bone mineral density in Addison\u2019s disease","volume":"58","author":"Jodar","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614103762300_R33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1507\/endocrj.51.355","article-title":"An assessment of bone mineral density in patients with Addison\u2019s disease and isolated ACTH deficiency treated with glucocorticoid","volume":"51","author":"Chikada","year":"2004","journal-title":"Endocr J"},{"key":"2020071614103762300_R34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jbspin.2004.04.004","article-title":"Androgens and bone metabolism","volume":"72","author":"Alexandre","year":"2005","journal-title":"Joint Bone Spine"},{"key":"2020071614103762300_R35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0889-8529(02)00058-0","article-title":"Establishment of peak bone mass","volume":"32","author":"Mora","year":"2003","journal-title":"Endocrinol Metab Clin North Am"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/91\/11\/4453\/9062645\/jcem4453.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/91\/11\/4453\/9062645\/jcem4453.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T01:34:13Z","timestamp":1594949653000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/91\/11\/4453\/2656611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,1]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2005-2823","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,1]]}}}